HERZLIYA, Israel and CALGARY, Alberta, Oct. 9, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce […]
“The Market is growing rapidly, driven by its potential to transform healthcare by enabling personalized treatment and targeted therapies. With increasing investment and innovation, this market is expected to revolutionize the way diseases are diagnosed […]
Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Attacks MINNEAPOLIS, Oct. 9, 2024 /PRNewswire/ — ShiraTronics, a clinical-stage medical device company developing […]
First-of-its-kind survey shows primary care physicians and public have low awareness, low concerns despite global surge in life-threatening mosquito-borne diseases lacking effective therapies or vaccines NEW YORK, Oct. 9, 2024 /PRNewswire/ — Cure®, a healthcare innovation […]
COPENHAGEN, Denmark, Oct. 9, 2024 /PRNewswire/ — Antag Therapeutics, a leading biopharmaceutical company focused on targeting the Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor to pioneer novel treatments for obesity, today announced that the U.S. Food and […]